NCC Ltd. NSE: NCC | BSE: 500294

Strong Performer, Under Radar

Download real time

206.27 -3.51 (-1.67%)

36.81% Fall from 52W High

1.3M

NSE+BSE Volume

NSE 17 Oct, 2025 1:02 PM (IST)

NCC Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on NCC Ltd. from all sources in a single place.

16 Oct 2025, 02:56PM

206.27

-1.67%

Company Update

NCC Ltd - 500294 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

Disclosure regarding ESG Rating by CFC Finlease Private Limited

10 Oct 2025

206.27

-1.67%

Company Update

NCC Ltd - 500294 - Re-Lodgement Of Transfer Requests Of Physical Shares

BSE India

Re-lodgement of Transfer requests of Physical Shares

06 Oct 2025

206.27

-1.67%

Company Update

NCC Ltd - 500294 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018

26 Sep 2025

206.27

-1.67%

SAST

NCC Ltd - 500294 - Closure of Trading Window

BSE India

Intimation regarding Closure of Trading Window

17 Sep 2025

206.27

-1.67%

India among top global contributors in reporting drug adverse events: DGCI

Business Standard

India ranks among the top contributors globally in reporting adverse events, Drugs Controller General of India (DCGI) Dr Rajeev Raghuvanshi said on Wednesday. He made the remarks at an event as he highlighted the growing role of pharmacovigilance in safeguarding patient health. The Indian Pharmacopoeia Commission (IPC), functioning as the National Coordination Centre for the Pharmacovigilance Programme of India (NCC-PvPI), inaugurated the 5th National Pharmacovigilance Week (NPW) at the Bharat Mandapam Convention Centre. The National Pharmacovigilance Week is being observed from September 17 to September 23 under the theme 'Your Safety, Just a Click Away: Report to PvPI'. The week-long campaign aims to sensitise healthcare professionals, regulators, researchers and the public to actively report adverse drug reactions (ADRs) through simplified digital platforms. "Initiation of National Pharmacovigilance Week in the journey of pharmacovigilance in the country has changed the course

NCC Ltd. has lost -33.35% in the last 1 Year

17 Sep 2025, 12:04PM

206.27

-1.67%

Company Update

NCC Ltd - 500294 - Notice Of Petition Pursuant To The Scheme Of Arrangement Between NCC …

BSE India

Newspaper Publication regarding Notice of Petition.

16 Sep 2025, 10:53AM

206.27

-1.67%

2,091-crore order lifts NCC share price 5% today; top details inside

Business Standard

NCC share price moved northwards after securing an order worth approximately 2,090.5 crore from Water Resource Department, Bihar .

NCC Ltd. has lost -33.35% in the last 1 Year

NCC Shares In Focus On Winning Rs 2,090-Crore Reservoir-Construction Order

NDTV Profit | 15 Sep 2025, 05:14PM

15 Sep 2025, 04:32PM

206.27

-1.67%

Company Update

NCC Ltd - 500294 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order

BSE India

Disclosure regarding receipt of Major Order

15 Sep 2025, 02:28PM

206.27

-1.67%

Company Update

NCC Ltd - 500294 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication regarding "100 days Campaign-Saksham Niveshak"

11 Sep 2025

206.27

-1.67%

Company Update

NCC Ltd - 500294 - Re-Lodgement Of Transfer Requests Of Physical Shares.

BSE India

Re-lodgement of Transfer requests of Physical Shares.

Is NCC Ltd. worth buying?

1863 Votes:

Buy 81.48%

Sell 9.72%

Hold 8.8%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >